Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Women’s Aspirin Plus Calcium Available Nationwide In February

This article was originally published in The Tan Sheet

Executive Summary

Labeling for Bayer Women's Aspirin Plus Calcium "analgesic/dietary supplement" features both a "Drug Facts" box and "Supplement Facts" information
Advertisement

Related Content

Bayer’s Aspirin/Phytosterols Combination May Draw FDA Warning
Bayer’s Aspirin/Phytosterols Combination May Draw FDA Warning
Bayer’s Aspirin/Phytosterols Combination May Draw FDA Warning
“Drug Facts” Labeling Proper Usage Dependant On Consumer Education – FDA
“Drug Facts” Labeling Proper Usage Dependant On Consumer Education – FDA
“Drug Facts” Labeling Proper Usage Dependant On Consumer Education – FDA
Bayer Women’s Aspirin Plus Calcium ads
Supplement/OTC Combos Have Precedents In Other Categories, Firms State
OTC/Dietary Supplement Combos Cited In FDA Warning Letters
OTC/Dietary Supplement Combos Cited In FDA Warning Letters

Topics

Advertisement
UsernamePublicRestriction

Register

PS093561

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel